The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data-Reference-Cited by-同舟云学术

The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data

Published:2021-10 Issue: Volume:72 Page:103574
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Glatman-Freedman Aharona,Bromberg Michal,Dichtiar Rita,Hershkovitz Yael,Keinan-Boker Lital

Funder

Ministry of Health, State of Israel

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference33 articles.

1. U.S. Food and Drug Administration. COVID-19 vaccines. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines. [Accessed 7 February, 2021].

2. European Medicines Agency. Treatments and vaccines for COVID-19: authorised medicines. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/treatments-vaccines-covid-19-authorised-medicines#covid-19-vaccines-section. [Accessed 7 February, 2021].

3. Our World in Data. Coronavirus (COVID-19) vaccination. https://ourworldindata.org/covid-vaccinations. [Accessed 25 May 2021].

4. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalizations and deaths followin nationwide vaccination campaign in Israel: an observational study using national surveillance data;Haas;Lancet,2021

5. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine;Polack;N Engl J Med,2020

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of COVID-19 vaccines against severe outcomes in cancer patients: Real-world evidence from self-controlled risk interval and retrospective cohort studies;Journal of Infection and Public Health;2024-05

2. Estimating All-Cause Deaths Averted in the First Two Years of the COVID-19 Vaccination Campaign in Italy;Vaccines;2024-04-13

3. Review of Israel’s action and response during the COVID-19 pandemic and tabletop exercise for the evaluation of readiness and resilience—lessons learned 2020–2021;Frontiers in Public Health;2024-01-24

4. Vaccinating against a Novel Pathogen: A Critical Review of COVID-19 Vaccine Effectiveness Evidence;Microorganisms;2023-12-31

5. Breakthrough SARS-COV-2 infection induces broad anti-viral T cell immunity;iScience;2023-12